{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:32:40Z","timestamp":1794645160873,"version":"4.9.1"},"reference-count":78,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCR"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>It is widely known that liver cirrhosis, regardless of the etiologies is accompanied by severe\nhemodynamic changes. The principal pathophysiological mechanisms are the hyperdynamic\ncirculation with increased cardiac output, heart rate along with reduced systemic vascular resistance.\nThus, counteractive mechanisms may develop that eventually lead to systolic as well as diastolic dysfunction\nand rhythm disturbances, in order to keep a steady homeostasis in the human body.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Literally, blunted contractile responsiveness to physical or pharmacological stress, impaired diastolic\nrelaxation and electrophysiological changes, primarily QT interval prolongation, do occur\nprogressively in a cirrhotic patient with no known preexisting cardiac disease. This condition is\nidentified as cirrhotic cardiomyopathy (CCM), an entity different from that seen in alcoholic cardiac\nmuscle disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>For the past decades, clinicians did study and attempt to understand the pathophysiology and clinical\nsignificance of this process. Indeed, various factors have been identified acting at the molecular\nand cellular level.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Electrocardiography, echocardiography and various serum biomarkers are the main tools that help\nhealthcare practitioners to point to the correct diagnosis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Noteworthy, the subjects that suffer from cirrhotic cardiomyopathy may progress to heart failure\nduring invasive procedures such as surgery, insertion of a transjugular intrahepatic portosystemic\nshunting (TIPS) and liver transplantation. Besides, several studies have illustrated that CCM is a\ncontributing factor, or even a precipitant, of hepatorenal syndrome (HRS), a conceivable reversible\nkidney failure in patients with liver cirrhosis and ascites.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>The treatment is the same as it is in the patients with liver cirrhosis and heart failure and there is no\nparticular treatment for cirrhotic cardiomyopathy. Hence, it is of utmost importance to clearly comprehend\nthe pathophysiology of this disease in order to design more accurate diagnostic tools and\ndefinitive treatments in a way to prevent the complications of cirrhosis and overt heart failure.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>The objective of this review is to describe in a comprehensive way the pathological alterations that\noccur in the cardiovascular system of cirrhotic patients. It will also point the limitations that remain in\nthe diagnosis and treatment strategies and more importantly, this review will alert the clinicians in the\nmodern era to further observe and record additional pathological changes in this subset of patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573403x15666190509084519","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T07:18:14Z","timestamp":1557472694000},"page":"78-84","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cirrhotic Cardiomyopathy: The Interplay Between Liver and Cardiac Muscle. How Does the Cardiovascular System React When the Liver is Diseased?"],"prefix":"10.2174","volume":"17","author":[{"given":"Spyros P.","family":"Dourakis","sequence":"first","affiliation":[{"name":"2nd Department of Internal Medicine and Research Laboratory, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens,Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Geladari","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Evaggelismos General Hospital, Athens,Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampia","family":"Geladari","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Evaggelismos General Hospital, Athens,Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Vallianou","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Evaggelismos General Hospital, Athens,Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","volume":"371","author":"Schuppan D.","year":"2008","unstructured":"Schuppan D.; Afdhal N.H.; Liver cirrhosis. Lancet 2008,371(9615),838-851","journal-title":"Lancet"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"15499","DOI":"10.3748\/wjg.v20.i42.15499","volume":"20","author":"M\u00f8ller S.","year":"2014","unstructured":"M\u00f8ller S.; Henriksen J.H.; Bendtsen F.; Extrahepatic complications to cirrhosis and portal hypertension: Haemodynamic and homeostatic aspects. World J Gastroenterol 2014,20(42),15499-15517","journal-title":"World J Gastroenterol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1007\/s10620-015-3752-3","volume":"60","author":"M\u00f8ller S.","year":"2015","unstructured":"M\u00f8ller S.; Bendtsen F.; Cirrhotic multiorgan syndrome. Dig Dis Sci 2015,60(11),3209-3225","journal-title":"Dig Dis Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","volume":"20","author":"Zhou W.C.","year":"2014","unstructured":"Zhou W.C.; Zhang Q.B.; Qiao L.; Pathogenesis of liver cirrhosis. World J Gastroenterol 2014,20(23),7312-7324","journal-title":"World J Gastroenterol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"11522","DOI":"10.3748\/wjg.v21.i41.11522","volume":"21","author":"Mart\u00ednez-Esparza M.","year":"2015","unstructured":"Mart\u00ednez-Esparza M.; Trist\u00e1n-Manzano M.; Ruiz-Alcaraz A.J.; Garc\u00eda-Pe\u00f1arrubia P.; Inflammatory status in human hepatic cirrhosis. World J Gastroenterol 2015,21(41),11522-11541","journal-title":"World J Gastroenterol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1172\/JCI102813","volume":"32","author":"Kowalski H.J.","year":"1953","unstructured":"Kowalski H.J.; Abelmann W.H.; The cardiac output at rest in Laennec\u2019s cirrhosis. J Clin Invest 1953,32(10),1025-1033","journal-title":"J Clin Invest"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1475-097X.1987.tb00631.x","volume":"7","author":"Kelbaek H.","year":"1987","unstructured":"Kelbaek H.; Rab\u00f8l A.; Brynjolf I.; Haemodynamic response to exercise in patients with alcoholic liver cirrhosis. Clin Physiol 1987,7(1),35-41","journal-title":"Clin Physiol"},{"key":"ref=8","first-page":"1131","volume":"26","author":"Pozzi M.","year":"1997","unstructured":"Pozzi M.; Carugo S.; Boari G.; Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997,26(5),1131-1137","journal-title":"Hepatology"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1042\/cs0970259","volume":"97","author":"Wong F.","year":"1999","unstructured":"Wong F.; Liu P.; Lilly L.; Bomzon A.; Blendis L.; Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. Clin Sci (Lond) 1999,97(3),259-267","journal-title":"Clin Sci (Lond)"},{"key":"ref=10","first-page":"44","volume":"85","author":"M\u00f8ller S.","year":"2009","unstructured":"M\u00f8ller S.; Henriksen J.H.; Cardiovascular complications of cirrhosis. Postgrad Med J 2009,85(999),44-54","journal-title":"Postgrad Med J"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jacc.2009.12.075","volume":"56","author":"Zardi E.M.","year":"2010","unstructured":"Zardi E.M.; Abbate A.; Zardi D.M.; Cirrhotic cardiomyopathy. J Am Coll Cardiol 2010,56(7),539-549","journal-title":"J Am Coll Cardiol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12072-014-9531-y","volume":"8","author":"Chayanupatkul M.","year":"2014","unstructured":"Chayanupatkul M.; Liangpunsakul S.; Cirrhotic cardiomyopathy: Review of pathophysiology and treatment. Hepatol Int 2014,8(3),308-315","journal-title":"Hepatol Int"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1002\/lt.500060510","volume":"6","year":"2000","unstructured":"11. Myers RP, Lee SS. Cirrhotic cardiomyopathy and liver transplantation. Liver Transpl 2000,6(4),S44-S52","journal-title":"Liver Transpl"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/lt.500040513","volume":"4","author":"Sampathkumar P.","year":"1998","unstructured":"Sampathkumar P.; Lerman A.; Kim B.Y.; Post-liver transplantation myocardial dysfunction. Liver Transpl Surg 1998,4(5),399-403","journal-title":"Liver Transpl Surg"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hep.1840120103","volume":"12","author":"Moreau R.","year":"1990","unstructured":"Moreau R.; Hadengue A.; Soupison T.; Abnormal pressor response to vasopressin in patients with cirrhosis: Evidence for impaired buffering mechanisms. Hepatology 1990,12(1),7-12","journal-title":"Hepatology"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/cs1010621","volume":"101","author":"Wong F.","year":"2001","unstructured":"Wong F.; Siu S.; Liu P.; Blendis L.M.; Brain natriuretic peptide: Is it a predictor of cardiomyopathy in cirrhosis? Clin Sci (Lond) 2001,101(6),621-628","journal-title":"Clin Sci (Lond)"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/gut.52.10.1511","volume":"52","author":"Henriksen J.H.","year":"2003","unstructured":"Henriksen J.H.; G\u00f8tze J.P.; Fuglsang S.; Christensen E.; Bendtsen F.; M\u00f8ller S.; Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut 2003,52(10),1511-1517","journal-title":"Gut"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/hep.510290332","volume":"29","author":"Pateron D.","year":"1999","unstructured":"Pateron D.; Beyne P.; Laperche T.; Elevated circulating cardiac troponin I in patients with cirrhosis. Hepatology 1999,29(3),640-643","journal-title":"Hepatology"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/hep.510270106","volume":"27","author":"Bernardi M.","year":"1998","unstructured":"Bernardi M.; Calandra S.; Colantoni A.; Q-T interval prolongation in cirrhosis: Prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology 1998,27(1),28-34","journal-title":"Hepatology"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1750-1172-2-15","volume":"2","author":"Baik S.K.","year":"2007","unstructured":"Baik S.K.; Fouad T.R.; Lee S.S.; Cirrhotic cardiomyopathy. Orphanet J Rare Dis [PUBMED: 17389039].2007,2,15","journal-title":"Orphanet J Rare Dis"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1097\/MEG.0b013e32833e6b2a","volume":"22","author":"Padillo J.","year":"2010","unstructured":"Padillo J.; Rioja P.; Mu\u00f1oz-Villanueva M.C.; BNP as marker of heart dysfunction in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2010,22(11),1331-1336","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.jhep.2007.02.001","volume":"46","author":"Arroyo V.","year":"2007","unstructured":"Arroyo V.; Terra C.; Gin\u00e8s P.; Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. J Hepatol 2007,46(5),935-946","journal-title":"J Hepatol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.dld.2006.12.014","volume":"39","author":"Milani A.","year":"2007","unstructured":"Milani A.; Zaccaria R.; Bombardieri G.; Gasbarrini A.; Pola P.; Cirrhotic cardiomyopathy. Dig Liver Dis 2007,39(6),507-515","journal-title":"Dig Liver Dis"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/hep.510230122","volume":"23","author":"Arroyo V.","year":"1996","unstructured":"Arroyo V.; Gin\u00e8s P.; Gerbes A.L.; Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996,23(1),164-176","journal-title":"Hepatology"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","volume":"38","author":"Ruiz-del-Arbol L.","year":"2003","unstructured":"Ruiz-del-Arbol L.; Urman J.; Fern\u00e1ndez J.; Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2003,38(5),1210-1218","journal-title":"Hepatology"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1053\/jhep.2003.50489","volume":"38","author":"Lee S.S.","year":"2003","unstructured":"Lee S.S.; Cardiac dysfunction in spontaneous bacterial peritonitis: A manifestation of cirrhotic cardiomyopathy? Hepatology 2003,38(5),1089-1091","journal-title":"Hepatology"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jhep.2005.10.034","volume":"44","author":"Zambruni A.","year":"2006","unstructured":"Zambruni A.; Trevisani F.; Caraceni P.; Bernardi M.; Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol 2006,44(5),994-1002","journal-title":"J Hepatol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.15403\/jgld.2014.1121.233.apac","volume":"23","author":"P\u00e1ll A.","year":"2014","unstructured":"P\u00e1ll A.; Czifra A.; Vit\u00e1lis Z.; Papp M.; Paragh G.; Szab\u00f3 Z.; Pathophysiological and clinical approach to cirrhotic cardiomyopathy. J Gastrointestin Liver Dis 2014,23(3),301-310","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12072-008-9109-7","volume":"3","author":"Wong F.","year":"2009","unstructured":"Wong F.; Cirrhotic cardiomyopathy. Hepatol Int 2009,3(1),294-304","journal-title":"Hepatol Int"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.transproceed.2011.01.188","volume":"43","author":"Timoh T.","year":"2011","unstructured":"Timoh T.; Protano M.A.; Wagman G.; Bloom M.; Vittorio T.J.; A perspective on cirrhotic cardiomyopathy. Transplant Proc 2011,43(5),1649-1653","journal-title":"Transplant Proc"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1478-3231.2005.01163.x","volume":"25","author":"Laleman W.","year":"2005","unstructured":"Laleman W.; Landeghem L.; Wilmer A.; Fevery J.; Nevens F.; Portal hypertension: from pathophysiology to clinical practice. Liver Int 2005,25(6),1079-1090","journal-title":"Liver Int"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"G980","DOI":"10.1152\/ajpgi.00336.2005","volume":"290","author":"Abraldes J.G.","year":"2006","unstructured":"Abraldes J.G.; Iwakiri Y.; Loureiro-Silva M.; Haq O.; Sessa W.C.; Groszmann R.J.; Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state. Am J Physiol Gastrointest Liver Physiol 2006,290(5),G980-G987","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1053\/jhep.2002.31432","volume":"35","author":"Wiest R.","year":"2002","unstructured":"Wiest R.; Groszmann R.J.; The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 2002,35(2),478-491","journal-title":"Hepatology"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/gut.49.1.112","volume":"49","author":"Henriksen J.H.","year":"2001","unstructured":"Henriksen J.H.; M\u00f8ller S.; Schifter S.; High arterial compliance in cirrhosis is related to elevated circulating calcitonin gene-related peptide (CGRP) and low adrenaline,but not to activated vasoconstrictor systems. Gut 2001,49,112-118","journal-title":"Gut"},{"key":"ref=35","first-page":"139","author":"M\u00f8ller S","year":"2005","unstructured":"M\u00f8ller S; Henriksen JH;  Ascites and Renal Dysfunction in Liver Disease 2005,139-155","journal-title":"Ascites and Renal Dysfunction in Liver Disease"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1478-3231.2006.01343.x","volume":"26","author":"M\u00f8ller S.","year":"2006","unstructured":"M\u00f8ller S.; Burchardt H.; \u00d8gard C.G.; Schi\u00f8dt F.V.; Lund J.O.; Pulmonary blood volume and transit time in cirrhosis: Relation to lung function. Liver Int 2006,26(9),1072-1078","journal-title":"Liver Int"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.amjmed.2006.05.007","volume":"119","author":"Schrier R.W.","year":"2006","unstructured":"Schrier R.W.; Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med 2006,119(7)(Suppl. 1),S47-S53","journal-title":"Am J Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0168-8278(03)00160-0","volume":"39","author":"Brinch K.","year":"2003","unstructured":"Brinch K.; M\u00f8ller S.; Bendtsen F.; Becker U.; Henriksen J.H.; Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease. J Hepatol 2003,39(1),24-31","journal-title":"J Hepatol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1172\/JCI106044","volume":"48","author":"Gould L.","year":"1969","unstructured":"Gould L.; Shariff M.; Zahir M.; Di Lieto M.; Cardiac hemodynamics in alcoholic patients with chronic liver disease and a presystolic gallop. J Clin Invest 1969,48(5),860-868","journal-title":"J Clin Invest"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S0002-9149(84)80220-9","volume":"54","author":"Kelbaek H.","year":"1984","unstructured":"Kelbaek H.; Eriksen J.; Brynjolf I.; Cardiac performance in patients with asymptomatic alcoholic cirrhosis of the liver. Am J Cardiol 1984,54(7),852-855","journal-title":"Am J Cardiol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/gut.49.2.268","volume":"49","author":"Wong F.","year":"2001","unstructured":"Wong F.; Girgrah N.; Graba J.; Allidina Y.; Liu P.; Blendis L.; The cardiac response to exercise in cirrhosis. Gut 2001,49(2),268-275","journal-title":"Gut"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1161\/01.CIR.49.4.755","volume":"49","author":"Limas C.J.","year":"1974","unstructured":"Limas C.J.; Guiha N.H.; Lekagul O.; Cohn J.N.; Impaired left ventricular function in alcoholic cirrhosis with ascites. Ineffectiveness of ouabain. Circulation 1974,49(4),754-760","journal-title":"Circulation"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/heart.87.1.9","volume":"87","author":"M\u00f8ller S.","year":"2002","unstructured":"M\u00f8ller S.; Henriksen J.H.; Cirrhotic cardiomyopathy: A pathophysiological review of circulatory dysfunction in liver disease. Heart 2002,87(1),9-15","journal-title":"Heart"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/liv.12263","volume":"33","author":"Baldassarre M.","year":"2013","unstructured":"Baldassarre M.; Giannone F.A.; Napoli L.; The endocannabinoid system in advanced liver cirrhosis: Pathophysiological implication and future perspectives. Liver Int [PUBMED: 23890208].2013,33(9),1298-1308","journal-title":"Liver Int"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0168-8278(96)80272-8","volume":"24","author":"van Obbergh L.","year":"1996","unstructured":"van Obbergh L.; Vallieres Y.; Blaise G.; Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related. J Hepatol [PUBMED: 8835751].1996,24(6),747-752","journal-title":"J Hepatol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/9780470987476.ch11","author":"Moller S.","year":"2005","unstructured":"Moller S.; Henriksen J.H.;  The systemic circulation in cirrhosis 2005,139-155","journal-title":"The systemic circulation in cirrhosis"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/S0140-6736(86)91556-4","volume":"1","author":"Gerbes A.L.","year":"1986","unstructured":"Gerbes A.L.; Remien J.; J\u00fcngst D.; Sauerbruch T.; Paumgartner G.; Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites. Lancet 1986,1(8495),1409-1411","journal-title":"Lancet"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1096\/fasebj.4.11.2165947","volume":"4","author":"Hausdorff W.P.","year":"1990","unstructured":"Hausdorff W.P.; Caron M.G.; Lefkowitz R.J.; Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J 1990,4(11),2881-2889","journal-title":"FASEB J"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1042\/cs1020213","volume":"102","author":"Garc\u00eda-Esta\u00f1 J.","year":"2002","unstructured":"Garc\u00eda-Esta\u00f1 J.; Ortiz M.C.; Lee S.S.; Nitric oxide and renal and cardiac dysfunction in cirrhosis. Clin Sci (Lond) 2002,102(2),213-222","journal-title":"Clin Sci (Lond)"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1056\/NEJMcp022709","volume":"351","author":"Aurigemma G.P.","year":"2004","unstructured":"Aurigemma G.P.; Gaasch W.H.; Clinical practice. Diastolic heart failure. N Engl J Med 2004,351(11),1097-1105","journal-title":"N Engl J Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1023\/A:1026503028065","volume":"5","author":"Little W.C.","year":"2000","unstructured":"Little W.C.; Kitzman D.W.; Cheng C.P.; Diastolic dysfunction as a cause of exercise intolerance. Heart Fail Rev 2000,5(4),301-306","journal-title":"Heart Fail Rev"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1665-2681(19)31544-3","volume":"10","author":"Ortiz-Olvera N.X.","year":"2011","unstructured":"Ortiz-Olvera N.X.; Castellanos-Pallares G.; G\u00f3mez-Jim\u00e9nez L.M.; Anatomical cardiac alterations in liver cirrhosis: an autopsy study. Ann Hepatol 2011,10(3),321-326","journal-title":"Ann Hepatol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.echo.2008.11.023","volume":"22","author":"Nagueh S.F.","year":"2009","unstructured":"Nagueh S.F.; Appleton C.P.; Gillebert T.C.; Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009,22(2),107-133","journal-title":"J Am Soc Echocardiogr"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/hep.20632","volume":"41","author":"Wiest R.","year":"2005","unstructured":"Wiest R.; Garcia-Tsao G.; Bacterial translocation (BT) in cirrhosis. Hepatology 2005,41(3),422-433","journal-title":"Hepatology"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1007\/s10620-013-2693-y","volume":"58","author":"Karagiannakis D.S.","year":"2013","unstructured":"Karagiannakis D.S.; Vlachogiannakos J.; Anastasiadis G.; Vafiadis-Zouboulis I.; Ladas S.D.; Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia. Dig Dis Sci 2013,58(10),3029-3036","journal-title":"Dig Dis Sci"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1161\/01.RES.68.3.745","volume":"68","author":"Fields N.G.","year":"1991","unstructured":"Fields N.G.; Yuan B.X.; Leenen F.H.; Sodium-induced cardiac hypertrophy. Cardiac sympathetic activity versus volume load. Circ Res 1991,68(3),745-755","journal-title":"Circ Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1210\/endo.141.5.7529","volume":"141","author":"Takeda Y.","year":"2000","unstructured":"Takeda Y.; Yoneda T.; Demura M.; Miyamori I.; Mabuchi H.; Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. Endocrinology 2000,141(5),1901-1904","journal-title":"Endocrinology"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/00365529609004879","volume":"31","author":"Finucci G.","year":"1996","unstructured":"Finucci G.; Desideri A.; Sacerdoti D.; Left ventricular diastolic function in liver cirrhosis. Scand J Gastroenterol 1996,31(3),279-284","journal-title":"Scand J Gastroenterol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0016-5085(97)70184-7","volume":"113","author":"Laffi G.","year":"1997","unstructured":"Laffi G.; Barletta G.; La Villa G.; Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. Gastroenterology 1997,113(3),891-898","journal-title":"Gastroenterology"},{"key":"ref=60","first-page":"119","author":"Ho C.Y.","year":"2006","unstructured":"Ho C.Y.;  Echocardiographic Assessment of Diastolic Function 2006,119-131","journal-title":"Echocardiographic Assessment of Diastolic Function"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/gut.2006.102467","volume":"56","author":"Cazzaniga M.","year":"2007","unstructured":"Cazzaniga M.; Salerno F.; Pagnozzi G.; Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut 2007,56(6),869-875","journal-title":"Gut"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","volume":"34","author":"M\u00f8ller S","year":"2013","unstructured":"M\u00f8ller S; Bernardi M; Interactions of the heart and the liver. Eur Heart J 2013,34(36),2804-2811","journal-title":"Eur Heart J"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1540-8167.2006.00622.x","volume":"18","author":"Zambruni A.","year":"2007","unstructured":"Zambruni A.; Di Micoli A.; Lubisco A.; Domenicali M.; Trevisani F.; Bernardi M.; QT interval correction in patients with cirrhosis. J Cardiovasc Electrophysiol 2007,18(1),77-82","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/hep.510230529","volume":"23","author":"Mohamed R.","year":"1996","unstructured":"Mohamed R.; Forsey P.R.; Davies M.K.; Neuberger J.M.; Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease. Hepatology 1996,23(5),1128-1134","journal-title":"Hepatology"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jhep.2005.04.015","volume":"43","author":"Ytting H.","year":"2005","unstructured":"Ytting H.; Henriksen J.H.; Fuglsang S.; Bendtsen F.; M\u00f8ller S.; Prolonged Q-T(c) interval in mild portal hypertensive cirrhosis. J Hepatol 2005,43(4),637-644","journal-title":"J Hepatol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"662","DOI":"10.4254\/wjh.v7.i4.662","volume":"7","author":"Mozos I.","year":"2015","unstructured":"Mozos I.; Arrhythmia risk in liver cirrhosis. World J Hepatol 2015,7(4),662-672","journal-title":"World J Hepatol"},{"key":"ref=67","author":"Batchvarov V","year":"2014","unstructured":"Batchvarov V; Camm AJ; QT dispersion: Measurement and interpretation. UpToDate 2014"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.transproceed.2010.12.002","volume":"43","author":"Shin W.J.","year":"2011","unstructured":"Shin W.J.; Kim Y.K.; Song J.G.; Alterations in QT interval in patients undergoing living donor liver transplantation. Transplant Proc 2011,43(1),170-173","journal-title":"Transplant Proc"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jhep.2007.11.012","volume":"48","author":"Zambruni A.","year":"2008","unstructured":"Zambruni A.; Trevisani F.; Di Micoli A.; Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. J Hepatol 2008,48(3),415-421","journal-title":"J Hepatol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1053\/gast.1997.v113.pm9247479","volume":"113","author":"Ruiz-del-Arbol L.","year":"1997","unstructured":"Ruiz-del-Arbol L.; Monescillo A.; Jimen\u00e9z W.; Garcia-Plaza A.; Arroyo V.; Rod\u00e9s J.; Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997,113(2),579-586","journal-title":"Gastroenterology"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0168-8278(05)80112-6","volume":"16","author":"Hendrickse M.T.","year":"1992","unstructured":"Hendrickse M.T.; Triger D.R.; Peripheral and cardiovascular autonomic impairment in chronic liver disease: Prevalence and relation to hepatic function. J Hepatol 1992,16(1-2),177-183","journal-title":"J Hepatol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"15492","DOI":"10.3748\/wjg.v20.i42.15492","volume":"20","author":"Gassanov N.","year":"2014","unstructured":"Gassanov N.; Caglayan E.; Semmo N.; Massenkeil G.; Er F.; Cirrhotic cardiomyopathy: A cardiologist\u2019s perspective. World J Gastroenterol 2014,20(42),15492-15498","journal-title":"World J Gastroenterol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/cld.141","volume":"2","author":"Bernardi M.","year":"2013","unstructured":"Bernardi M.; Cirrhotic cardiomyopathy. Clin Liver Dis (Hoboken) 2013,2(3),99-101","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1055\/s-2008-1040321","volume":"28","author":"Alqahtani S.A.","year":"2008","unstructured":"Alqahtani S.A.; Fouad T.R.; Lee S.S.; Cirrhotic cardiomyopathy. Semin Liver Dis 2008,28(1),59-69","journal-title":"Semin Liver Dis"},{"key":"ref=75","author":"Wiese S","year":"2014","unstructured":"Wiese S; Hove JD; Bendtsen F; M\u00f8ller S; Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jhep.2003.10.026","volume":"40","author":"Henriksen J.H.","year":"2004","unstructured":"Henriksen J.H.; Bendtsen F.; Hansen E.F.; M\u00f8ller S.; Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis. J Hepatol [PubMed: 14739094]2004,40(2),239-246","journal-title":"J Hepatol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/hep.23852","volume":"52","author":"Wong F.","year":"2010","unstructured":"Wong F.; Salerno F.; Beta-blockers in cirrhosis: Friend and foe? Hepatology [PubMed: 20812354]2010,52(3),811-813","journal-title":"Hepatology"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"Pitt B.","year":"1999","unstructured":"Pitt B.; Zannad F.; Remme W.J.; The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999,341(10),709-717","journal-title":"N Engl J Med"}],"container-title":["Current Cardiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/172042","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/172042\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/172042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T15:50:04Z","timestamp":1648482604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/172042\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573403x15666190509084519","relation":{},"ISSN":["1573-403X"],"issn-type":[{"value":"1573-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-03-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}